ARK Genomic Revolution ETF vs Stitch Fix Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.84, while Stitch Fix Inc trades at $3.6 (market cap $475.00M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Stitch Fix Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | SFIX | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $5.83 |
52-Week Low | $23.09 | $3.06 |
Market Cap | — | $475.00M |
Enterprise Value | — | $362.71M |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Stitch Fix (SFIX) trades at $3.56, up 1.14% today, showing signs of a potential turnaround despite technical bearish signals. The company has demonstrated improving fundamentals with three consecutive quarterly earnings beats and narrowing losses, while revenue has stabilized around $1.3 billion. Recent news highlights AI-driven personalization initiatives and growing client spending, though the stock remains near historic lows with a bearish technical outlook.
The outlook suggests cautious optimism as SFIX executes its turnaround strategy, with analyst consensus pointing to 33% upside potential. Key risks include ongoing net losses, competitive pressures in online retail, and execution challenges in maintaining client growth momentum. The stock presents a high-risk opportunity for investors betting on the company's AI-driven personalization strategy and margin improvement trajectory.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →